Neomycin
Neomycin is an aminoglycoside antibiotic used to treat or prevent certain bacterial infections, particularly susceptible infections involving the skin, eyes, ears, and gastrointestinal tract, depending on the formulation. It works by binding to the bacterial 30S ribosomal subunit, disrupting protein synthesis and preventing bacterial growth. Neomycin is available in topical creams, ointments, eye and ear preparations, and oral formulations for specific clinical uses. Common side effects include skin irritation, redness, itching, and gastrointestinal discomfort with oral use. Systemic absorption, particularly from damaged skin or prolonged use, may cause serious kidney damage and hearing or balance impairment; it can also trigger allergic contact dermatitis. Neomycin should be used only for appropriate bacterial infections under medical guidance, with particular caution in patients with kidney problems or pre-existing hearing disorders.
Neomycin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Neomycin, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Neomycin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Neomycin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
